Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 2,361 $ 2,557 $ 5,233 $ 3,957
General and administrative 1,375 1,271 2,708 2,609
Legal settlement 1,600 1,600
Impairments 19,092 19,092
Total operating expenses 24,428 3,828 28,633 6,566
Loss from operations (24,428) (3,828) (28,633) (6,566)
Other (expense) income:        
Interest expense, net (2) (1) (3)
Foreign exchange gain (1) (14)
Change in fair value of derivative liabilities 1 9 12 10
Total other expense, net 7 (3) 7
Net loss $ (24,428) $ (3,821) $ (28,636) $ (6,559)
Net loss per common share, basic and diluted $ (0.25) $ (0.04) $ (0.29) $ (0.08)
Weighted average number of common shares outstanding, basic and diluted 97,469 87,069 97,469 79,116